Akamai Technologies, Inc. (NASDAQ:AKAM – Get Free Report) was the target of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 9,110,000 shares, a growth of 14.0% from the October 15th total of 7,990,000 shares. Based on an average daily volume of 1,520,000 shares, the short-interest ratio is currently 6.0 days. Approximately 6.1% of the company’s shares are sold short.
Akamai Technologies Price Performance
Shares of NASDAQ:AKAM opened at $87.43 on Monday. The company has a current ratio of 1.33, a quick ratio of 1.32 and a debt-to-equity ratio of 0.50. The stock has a market cap of $13.13 billion, a PE ratio of 25.87, a price-to-earnings-growth ratio of 3.33 and a beta of 0.68. The stock’s fifty day simple moving average is $99.84 and its two-hundred day simple moving average is $96.73. Akamai Technologies has a 1-year low of $86.78 and a 1-year high of $129.17.
Insider Activity at Akamai Technologies
In other news, EVP Paul C. Joseph sold 4,000 shares of the stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $97.30, for a total value of $389,200.00. Following the completion of the sale, the executive vice president now owns 30,703 shares of the company’s stock, valued at approximately $2,987,401.90. This represents a 11.53 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director William Raymond Wagner sold 1,000 shares of Akamai Technologies stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average price of $100.73, for a total value of $100,730.00. Following the completion of the transaction, the director now directly owns 16,719 shares in the company, valued at approximately $1,684,104.87. This represents a 5.64 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 11,500 shares of company stock worth $1,065,975 over the last three months. Company insiders own 1.80% of the company’s stock.
Institutional Inflows and Outflows
Analyst Ratings Changes
A number of analysts have weighed in on the company. HSBC upgraded Akamai Technologies from a “hold” rating to a “buy” rating and set a $121.00 price target for the company in a report on Monday, November 11th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $100.00 target price on shares of Akamai Technologies in a report on Thursday, August 15th. Hsbc Global Res upgraded Akamai Technologies from a “hold” rating to a “strong-buy” rating in a report on Monday, November 11th. Scotiabank lowered their price objective on shares of Akamai Technologies from $115.00 to $112.00 and set a “sector outperform” rating for the company in a research note on Friday, November 8th. Finally, Tigress Financial reissued a “strong-buy” rating and set a $140.00 target price on shares of Akamai Technologies in a research note on Thursday, August 29th. One research analyst has rated the stock with a sell rating, five have given a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $117.47.
Check Out Our Latest Analysis on Akamai Technologies
About Akamai Technologies
Akamai Technologies, Inc provides cloud computing, security, and content delivery services in the United States and internationally. The company offers cloud solutions to keep infrastructure, websites, applications, application programming interfaces, and users safe from various cyberattacks and online threats while enhancing performance.
See Also
- Five stocks we like better than Akamai Technologies
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- What is an Earnings Surprise?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Akamai Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akamai Technologies and related companies with MarketBeat.com's FREE daily email newsletter.